ALEXANDRIA, Va. -- The American Society of Clinical Oncology, Inc. (ASCO®) today issued recommendations addressing the needs of sexual and gender minority (SGM) populations as they relate to cancer. The recommendations, published in a policy statement in the Journal of Clinical Oncology, are designed to focus attention on the challenges facing the SGM community--including discrimination and greater risk of anxiety and depression, resulting in disparate care--and concrete steps that can help minimize health disparities among SGM individuals.
The American Society of Clinical Oncology (ASCO) has released a set of recommendations to enhance the role of observational cancer research in clinical decision-making. Published in the Journal of Clinical Oncology (JCO), the ASCO research statement discusses the expanding opportunities to utilize observational studies to advance cancer research and supplement the knowledge gained through cancer clinical trials.
Alexandria, Va.—CancerLinQ LLC is partnering with the leading association for hematology/oncology pharmacy professionals, the Hematology/Oncology Pharmacy Association (HOPA). CancerLinQ will draw on the expertise of HOPA and its members as it continues to roll out CancerLinQ’s core quality improvement and data-sharing platform to oncology practices and cancer centers. Beginning next year, HOPA will have access to data-driven insights from CancerLinQ Discovery™ to educate its member pharmacists, who play a vital role in the cancer care team.
WASHINGTON – The U.S. cancer care delivery system is undergoing profound changes to better meet the needs of people with cancer, but persistent hurdles threaten to slow progress, according to the American Society of Clinical Oncology’s (ASCO) fourth annual State of Cancer Care in America report released today.
ALEXANDRIA, Va. -- QOPI Certification Program LLC (QCP), an affiliate of the American Society of Clinical Oncology, Inc. (ASCO) that runs the QOPI Certification Program™, and the Foundation for Excellence and Quality in Oncology (ECO), a nonprofit foundation in Spain, have launched an effort to expand the QOPI Certification Program to Spain. Through the collaboration between ECO and QCP, Spanish oncology practices will be able to apply for QOPI Certification.
We soundly oppose President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health (NIH). Reducing NIH’s funding by nearly 20 percent will devastate our nation’s already fragile federal research infrastructure and undercut a longstanding commitment to biomedical science that has fueled advances in cancer prevention, diagnosis, and treatment.
ALEXANDRIA, Va. -- On March 22, 2017, the American Society of Clinical Oncology (ASCO) will release The State of Cancer Care in America: 2017 report, which examines the current landscape of the cancer care delivery system in the United States, and outlines key opportunities and challenges facing cancer care providers and patients today.
“The American Society of Clinical Oncology (ASCO) congratulates Seema Verma for her confirmation as Administrator of the Centers for Medicare & Medicaid Services (CMS). Administrator Verma is now in a key position to lead the agency during the next phase of healthcare reform in the United States, and to help ensure that millions of Medicare and Medicaid beneficiaries with cancer have access to high-quality oncology care."
ALEXANDRIA, Va. -- CancerLinQ LLC, a wholly-owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO), and the Oncology Nursing Society (ONS) announced today the formation of the CancerLinQ® Ambassadors Program. This new collaboration is a national practice engagement initiative that will provide on-the-ground support and guidance to CancerLinQ® participating practices on a regional basis.
ALEXANDRIA, Va. – CancerLinQ LLC and the American Society for Radiation Oncology (ASTRO) are partnering to bring radiation oncology expertise to CancerLinQ® and improve the care of cancer patients nationwide. ASTRO will provide guidance for the development of the CancerLinQ® platform to ensure that the system captures more relevant patient data to drive actionable decision-making in cancer care, as well as to advance public policy and population health issues. ASTRO also will use insights from CancerLinQ Discovery™ to improve the care of patients receiving radiation therapy.
“ASCO congratulates Representative Tom Price for his confirmation as Secretary of the U.S. Department of Health and Human Services (HHS). Secretary Price has a unique opportunity to shape the availability and quality of care for millions of people with cancer and maintain the nation’s leadership in biomedical research."
ALEXANDRIA, Va. – CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that the University of Virginia (UVA) Cancer Center has signed an agreement to participate in the CancerLinQ® platform.
On January 24, 2017, the Journal of the American Medical Association (JAMA), published “Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014” by Modak et al. The study found that cancer deaths in the U.S. declined by 20 percent from 1980-2014, but there were large differences in cancer mortality as well as areas with unusually higher mortality rates across counties. The following is a statement from Daniel F. Hayes, MD, FACP, FASCO, President of the American Society of Clinical Oncology (ASCO).
Alexandria, Va. – The American Society of Clinical Oncology (ASCO) released, “ASCO Principles for Patient-Centered Healthcare Reform,” seven recommendations designed to ensure access to high-quality cancer care amid the changing U.S. healthcare delivery landscape. The principles aim to assist the new Congress and Administration, so, as they consider the critical underpinnings of any healthcare reform proposal, the needs of patients facing a cancer diagnosis are met.
ALEXANDRIA, Va. -- CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that George A. Komatsoulis, Ph.D., will be its first Chief of Bio-Informatics. This marks another step toward the organization's goal of making the CancerLinQ® platform the premier system for unlocking patient data from millions of electronic health records (EHR), breaking down silos among various EHR systems and providers, and securely processing and analyzing the data to give personalized insights than can improve the quality of care for patients with cancer.